Waxaa la aasaasay 2009, JYMed waa shirkad dawooyin ah oo ku taal Shiinaha oo isku xirta R&D, wax-soo-saarka, ganacsiga, iyo horumarinta gaarka ah iyo soosaarka alaabada peptide. Shirkaddu waxay leedahay qiyaastii 570 shaqaale ah, oo leh koox maareyn xudun u ah oo ka kooban xirfadlayaal leh khibradda daawooyinka iyo in ka badan 20 sano oo waayo-aragnimo ah warshadaha peptide. JYMed waxay ka shaqeysaa hal xarun cilmi baaris iyo laba tas-hiilaad wax soo saar oo waaweyn, iyadoo ku gaareysa awoodda wax-soo-saarka miisaanka badan ee peptides, iyada oo u dhiganta hoggaamiye warshadeed.
JYMed waxay bixisaa faylal kala duwan oo peptide APIs ah, oo ay ku jiraan in ka badan 20 nooc sida Semaglutide, Tirzepatide, Liraglutide, Degarelix, iyo Oxytocin. Kuwaas waxaa ka mid ah, shan alaab, oo ay ku jiraan Semaglutide iyo Tirzepatide, ayaa si guul leh u dhammaystiray diiwaangelinta FDA Drug Master File (DMF).
JYMed waxay bixisaa peptides la isku qurxiyo oo tayo sare leh, alaabta ceeriin, iyo adeegyada qaabaynta OEM laga bilaabo darajada cilmi baarista ilaa darajada cGMP, dhamaantood leh kontorool tayo adag. peptides-ka synthetic-ka ah, oo caan ku ah badbaadadooda iyo fududaynta wax ka beddelka, ayaa ah maaddooyinka lagama maarmaanka u ah warshadaha qurxinta, bixinta faa'iidooyinka la xaqiijiyay ee daryeelka timaha, bogsiinta boogaha, gabowga ka hortagga, laalaab-qaadista, caddeynta, iyo koritaanka indhaha.
JYMed waxay leedahay nidaam warshadaynta peptide oo dhamaystiran oo hufan, oo siisa macaamiisha adeegyo buuxa oo loogu talagalay peptide iyo peptide-analog, oo ay ku jiraan cilmi baarista iyo soosaarka peptides-ka daweynta, peptides-ka xoolaha, peptides-ka qurxinta, iyo RNA, oo ay weheliso taageerada diiwaangelinta iyo u hoggaansanaanta sharciga. .
Shirkad ku jihaysan macmiilka, JYMed waxay leedahay nidaam warshadayneed oo peptide ah oo dhamaystiran, oo leh in ka badan 20 sano oo waayo-aragnimo ah peptide R&D iyo tas-hiilaad casri ah. Waxaan bixinaa noocyo kala duwan oo peptides tayo sare leh oo ku saleysan baahida macmiilka: Tirada laga bilaabo mg ilaa kg, nadiifinta cayriin ilaa> 99%, laga bilaabo GMP-ga ilaa heerka GMP, laga bilaabo peptides fudud ilaa peptides wax laga beddelay, horumarinta peptides antigenic, heshiis qarsoodi ah ayaa diyaar ah.
Horudhaca JYMed, oo ah FDA-da Maraykanka ayaa baadhay soo saaraha peptide. Alaabooyinka la soo bandhigay: peptides la isku qurxiyo, peptide APIs, peptides caadadii, sida, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, iwm. Si aad wax badan u ogaato, fadlan la xidhiidh
Email: jymed@jymedtech.com
Dhawaan, xarunta wax soo saarka peptide ee JYMed, Hubei Jianxiang Biopharmaceutical Co., Ltd., waxay heshay laba dukumeenti rasmi ah oo ay soo saartay Maamulka Dawooyinka Gobolka Hubei: "Ogaysiinta Natiijadda Kormeerka U Hogaansanaanta Dawooyinka" (No. E GMP 2024-258 iyo No. GMP 2024-260) a...
Laga bilaabo Agoosto 26 ilaa Agoosto 30, 2024, xarunta wax soo saarka peptide ee JYMed, Hubei JX Bio-Pharmaceutical Co., Ltd., waxay si guul leh ugu gudubtay kormeer goob ah oo ay samaysay Maamulka Cuntada iyo Dawooyinka ee Maraykanka (FDA). Kormeerka ayaa waxa uu ku saabsanaa goobo muhiim ah...
01. Dulmarka Bandhiga Oktoobar 8-deedii, 2024-kii CPHI Worldwide Pharmaceutical Exhibition ayaa ka bilaabmay Milan. Sida mid ka mid ah dhacdooyinka ugu muhiimsan ee sanadlaha ah ee warshadaha dawooyinka caalamiga ah, waxay soo jiidatay ka qaybgalayaasha 166 waddan iyo gobollada. Iyadoo la dhameeyay...